User profiles for Gerald C Smaldone

Gerald C Smaldone MD, PhD

Professor of Medicine, Physiology and Biophysics
Verified email at stonybrook.edu
Cited by 10201

Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and …

…, P Anderson, R Dhand, JL Rau, GC Smaldone… - Chest, 2005 - Elsevier
Background The proliferation of inhaler devices has resulted in a confusing number of
choices for clinicians who are selecting a delivery device for aerosol therapy. There are …

Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit

LB Palmer, GC Smaldone, JJ Chen, D Baram… - Critical care …, 2008 - journals.lww.com
Objective: The purpose of this study was to determine whether aerosolized antibiotics,
which achieve high drug concentrations in the target organ, would more effectively treat …

Aerosol Delivery and Modern Mechanical Ventilation: In Vitro/In Vivo Evaluation

…, LB Palmer, AR Shah, GC Smaldone - American journal of …, 2003 - atsjournals.org
… Correspondence and requests for reprints should be addressed to Gerald C. Smaldone,
Pulmonary and Critical Care Medicine, T17, 040 Health Science Center, State University of New …

[HTML][HTML] A randomized trial of inhaled cyclosporine in lung-transplant recipients

…, DA Seiler, JH Dauber, GC Smaldone… - … England Journal of …, 2006 - Mass Medical Soc
Background Conventional regimens of immunosuppressive drugs often do not prevent
chronic rejection after lung transplantation. Topical delivery of cyclosporine in addition to …

Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine

…, R MacLoughlin, GC Smaldone… - Journal of aerosol …, 2020 - liebertpub.com
National and international guidelines recommend droplet/airborne transmission and contact
precautions for those caring for coronavirus disease 2019 (COVID-19) patients in …

Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit

LB Palmer, GC Smaldone - … journal of respiratory and critical care …, 2014 - atsjournals.org
Rationale: Multidrug-resistant organisms (MDRO) are the dominant airway pathogens in the
intensive care unit (ICU) and present a major treatment challenge to intensivists. …

Aerosolized antibiotics in mechanically ventilated patients: delivery and response

LB Palmer, GC Smaldone, SR Simon… - Critical care …, 1998 - journals.lww.com
… The response was assessed by a) changes in the volume of respiratory secretions; b)
effect on bacterial cultures; and c) changes in the inflammatory cells and mediators of …

Oral clearance and pathogenic oropharyngeal colonization in the elderly

…, AM Filkin, S Simon, GC Smaldone - American journal of …, 2001 - atsjournals.org
The elderly have an increased incidence of oropharyngeal colonization with respiratory
pathogens, a well-known risk factor for the development of pneumonia. Changes in the oral …

Nebulizer function during mechanical ventilation1-3

…, MJ Greco, RJ Perry, GC Smaldone - Am Rev Respir Dis, 1992 - atsjournals.org
… 3 Correspondence and requests for reprints should be addressed to Gerald C. Smaldone,
MD, Ph.D., Pulmonary Disease Division, State University of New York at Stony Brook, HSC Tl7…

Quantitative deposition of aerosolized gentamicin in cystic fibrosis1-3

JS Ilowite, JD Gorvoy, GC Smaldone - Am Rev Respir Dis, 1987 - atsjournals.org
In cystic fibrosis (CF), the clinical effectiveness of aerosolized antibiotics is controversial.
Previous investigators have not considered the type of nebulizer, droplet size, and dose to the …